Defining Islet Heterogeneity Using Single Islet Transcriptomics
Defining Islet Heterogeneity Using Single Islet Transcriptomics
批准号:
8812982
负责人:
MARTHA CAMPBELL-THOMPSON
金额:
$159.77万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-19 至 2018-08-31
关键词:
AddressAnimal ModelAnimalsAntibodiesAreaAutoantibodiesBeta CellBiologicalCD3 AntigensCell DeathCell SurvivalCellsCellular StressCollaborationsComplexCritical PathwaysCrude ExtractsCryoultramicrotomyDataDevelopmentDiabetes MellitusDiabetes autoantibodiesDiseaseDisease MarkerFluorescence MicroscopyFreezingFunctional disorderGene ExpressionGene Expression ProfileGene Expression ProfilingGenesHeadHeterogeneityHumanImmuneImmune System and Related DisordersImmunofluorescence ImmunologicIndividualInflammationInsulinInsulin-Dependent Diabetes MellitusLasersLeukocytesMeasuresMetabolic stressMethodsMicrodissectionMicroscopeMissionMolecularMolecular ProfilingOrganOrgan DonorPancreasParaffin EmbeddingPathway interactionsPatternPhenotypeProcessProcess MeasureProtocols documentationRNAReportingResearchResearch PersonnelSerumStagingStaining methodStainsStressSurveysSystemT-LymphocyteTailTechnologyTherapeuticTimeTissuesViral MarkersVirus Diseasesbasecell injurydiabeticinsightinterestisletlaser capture microdissectionnew technologynon-diabeticnovelnovel strategiesnovel therapeuticspreventpublic health relevanceresearch and developmenttooltranscriptomicstype I diabetic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our studies are focused on examination of single islet gene expression profiles (transcriptomes) to determine pathways critical to human beta cell death and survival. In preliminary studies we have developed new approaches and protocols that allow laser-capture of individual islets from cryosections of human pancreas, extract the RNA, and obtain comprehensive transcriptomes. Our proposal to the HIRN-CBDS consortium is based on using and expanding these proven protocols to gain deeper insights into islet heterogeneity and differences in gene expression patterns of individual islets from individuals with and without diabetes and with or without serum autoantibodies (AAB). Based on preliminary data in islets from non-diabetic individuals with or without AAB, we hypothesize that islets develop a gene expression signature of "cellular stress" before the early stages of insuliti. A full characterization of early abnormalities in islet gene expression signatures could point to novel mechanisms of disease and new therapeutic strategies that target islet abnormalities to delay or prevent beta cell death. The use of comprehensive gene expression profiling of thousands of expressed genes will allow a very detailed look at specific pathways and processes. Our proposal has the following specific aims: Specific Aim 1. To characterize transcriptomes of individual islets in a survey of islets from different regions of the pancreas an from organ donors with or without autoantibodies (AAB) and with or without diabetes. This will provide an unbiased survey of islet gene expression and its heterogeneity. Specific Aim 2. To characterize transcriptomes of individual islets selected by rapid immuno-laser capture microdissection for the presence or absence of insulin-positive beta cells and presence or absence of CD3 T-cells. In this aim we will obtain expression profiles from islets that have been selected based on multiple fluorescent stains for beta cells and insulitis. We will develop protocols for using rapid immunofluorescence that provide high quality RNA and then directly microdissect islets, across serial sections, based on their staining patterns. Specific Aim 3. To characterize transcriptomes of individual islets selected for staining patterns of markers of viral
presence and metabolic stress. In this aim we will use our newly acquired ability to conduct multiplexed immunofluorescence to define islets with novel complex phenotypes indicative of stress due to viral infections or metabolic stress. In this aim phenotypes will be highly complex and we will stain one tissue section and then capture individual islets of interest from adjacent serial tissue sections. Mechanistic studies using isolated islets will follow from all specific aim as new pathways of cellular destruction or survival are discovered.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/s41598-023-39243-x
发表时间:
2023-08-09
期刊:
SCIENTIFIC REPORTS
影响因子:
4.6
作者:
[Leung, Sherman S., Lenchik, Nataliya, Mathews, Clayton, Pugliese, Alberto, McCarthy, Domenica A., Le Bagge, Selena, Ewing, Adam, Harris, Mark, Radford, Kristen J., Borg, Danielle J., Gerling, Ivan, Forbes, Josephine M.]
通讯作者:
Forbes, Josephine M.
DOI:
10.1007/s00125-021-05469-5
发表时间:
2021-08
期刊:
Diabetologia
影响因子:
8.2
作者:
[Pedersen K, Haupt-Jorgensen M, Krogvold L, Kaur S, Gerling IC, Pociot F, Dahl-Jørgensen K, Buschard K]
通讯作者:
Buschard K
DOI:
10.1038/s41467-022-28360-2
发表时间:
2022-02-03
期刊:
Nature communications
影响因子:
16.6
作者:
[D'Addio F, Maestroni A, Assi E, Ben Nasr M, Amabile G, Usuelli V, Loretelli C, Bertuzzi F, Antonioli B, Cardarelli F, El Essawy B, Solini A, Gerling IC, Bianchi C, Becchi G, Mazzucchelli S, Corradi D, Fadini GP, Foschi D, Markmann JF, Orsi E, Škrha J Jr, Camboni MG, Abdi R, James Shapiro AM, Folli F, Ludvigsson J, Del Prato S, Zuccotti G, Fiorina P]
通讯作者:
Fiorina P
DOI:
10.2337/db15-0779
发表时间:
2016-03
期刊:
Diabetes
影响因子:
7.7
作者:
[Campbell-Thompson M, Fu A, Kaddis JS, Wasserfall C, Schatz DA, Pugliese A, Atkinson MA]
通讯作者:
Atkinson MA
DOI:
10.1007/s00125-018-4614-2
发表时间:
2018-07
期刊:
Diabetologia
影响因子:
8.2
作者:
[Holm LJ, Krogvold L, Hasselby JP, Kaur S, Claessens LA, Russell MA, Mathews CE, Hanssen KF, Morgan NG, Koeleman BPC, Roep BO, Gerling IC, Pociot F, Dahl-Jørgensen K, Buschard K]
通讯作者:
Buschard K
共 6 条
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
-
批准号:10461979
-
项目类别:
-
资助金额:$64.11万
-
财政年份:2020
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Multi-omic 3D tissue maps for a Human BioMolecular Atlas
-
批准号:10685583
-
项目类别:
-
资助金额:$194.73万
-
财政年份:2020
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
-
批准号:10226911
-
项目类别:
-
资助金额:$64.11万
-
财政年份:2020
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
-
批准号:10202585
-
项目类别:
-
资助金额:$74.01万
-
财政年份:2019
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
-
批准号:10441263
-
项目类别:
-
资助金额:$73.21万
-
财政年份:2019
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
-
批准号:9802936
-
项目类别:
-
资助金额:$74.94万
-
财政年份:2019
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Neuromodulation-based treatment of diabetes: identifying anatomical and physiological pancreatic innervation targets
-
批准号:9752693
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2016
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pancreas Volume in Preclinical Type 1 Diabetes
-
批准号:8644494
-
项目类别:
-
资助金额:$139.85万
-
财政年份:2013
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Leica Laser Microdissection Microscope for a Shared Resource
-
批准号:8448032
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2013
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pathology/Immunology Core
-
批准号:8319521
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2011
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pathology/Immunology Core
-
批准号:7681501
-
项目类别:
-
资助金额:$15.37万
-
财政年份:2008
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Core--Pathology/Immunology
-
批准号:7489006
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2007
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pathology/Immunology Core
-
批准号:7185723
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2006
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Core--Pathology/Immunology
-
批准号:7017400
-
项目类别:
-
资助金额:$20.6万
-
财政年份:2005
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Alternative Estrogen Replacement Therapy for Colon Canc*
-
批准号:6676108
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2003
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Alternative Estrogen Replacement Therapy for Colon Canc*
-
批准号:6765218
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2003
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Core--Pathology/Immunology
-
批准号:7311632
-
项目类别:
-
资助金额:$20.98万
-
财政年份:--
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Core--Pathology/Immunology
-
批准号:7918799
-
项目类别:
-
资助金额:$17.73万
-
财政年份:--
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pathology/Immunology Core
-
批准号:8131064
-
项目类别:
-
资助金额:$15.99万
-
财政年份:--
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
Pathology/Immunology Core
-
批准号:7935311
-
项目类别:
-
资助金额:$16.04万
-
财政年份:--
-
负责人:MARTHA CAMPBELL-THOMPSON
-
依托单位:
海外基金